Featured
Pancreatic Cancer Breakthrough: New Targeted Drug Daraxonrasib Doubles Survival Rates
A novel targeted therapy, daraxonrasib, has demonstrated an unprecedented ability to nearly double the survival rate for patients with advanced pancre...
Read Full Story →